Fidelity International’s Emergent Biosolutions EBS Stock Holding History

Fidelity International’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-97,271	Closed	-$4.91M	–	941
2018 Q2	$4.91M	Sell	97,271 -42,525	-30%	-$2.22M	0.01%	554
2018 Q1	$7.36M	Sell	139,796 -128,624	-48%	-$6.41M	0.02%	379
2017 Q4	$12.5M	Sell	268,420 -267,258	-50%	-$11.2M	0.03%	322
2017 Q3	$21.7M	Sell	535,678 -63,565	-11%	-$2.3M	0.06%	235
2017 Q2	$20.3M	Sell	599,243 -71,491	-11%	-$2.21M	0.06%	239
2017 Q1	$19.5M	Sell	670,734 -54,260	-7%	-$1.65M	0.05%	258
2016 Q4	$23.8M	Buy	724,994 +122,200	+20%	+$3.66M	0.07%	221
2016 Q3	$19M	Buy	602,794 +31,579	+6%	+$918K	0.06%	254
2016 Q2	$16.1M	Buy	+571,215	New	+$22.4M	0.05%	283

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fidelity International's EBS Position: Q3 2018 in Review

Fidelity International sold out of Emergent Biosolutions (EBS) in Q3 2018, closing a stake of 97,271 shares — an estimated $4.91M sold.

Fidelity International first reported a position in EBS in Q2 2016 and held it in 9 quarters. The position peaked at $23.8M in Q4 2016. 275 funds tracked by Wall St. Rank hold EBS as of Q3 2018.

Fidelity International reported no remaining Emergent Biosolutions position as of Q3 2018 after selling out during the quarter.
Fidelity International sold 97,271 Emergent Biosolutions shares in Q3 2018, an estimated $4.91M.
Fidelity International first reported a position in Emergent Biosolutions in Q2 2016 and held it in 9 quarters.
Fidelity International's Emergent Biosolutions position peaked at $23.8M in Q4 2016.
275 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2018.

Based on Fidelity International's 13F filing for Q3 2018, filed 9 Nov 2018.